In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
TG Therapeutics Inc (NASDAQ: TGTX) closed the day trading at $23.13 down -4.62% from the previous closing price of $24.25. In other words, the price has decreased by -$4.62 from its previous closing price. On the day, 2.34 million shares were traded. TGTX stock price reached its highest trading level at $24.27 during the session, while it also had its lowest trading level at $23.0.
Ratios:
For a better understanding of TGTX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.80. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.58. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on August 02, 2023, Upgraded its rating to Neutral and sets its target price to $12 from $16 previously.
On May 20, 2022, BofA Securities started tracking the stock assigning a Underperform rating and target price of $5.BofA Securities initiated its Underperform rating on May 20, 2022, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’24 when Lonial Sagar sold 16,348 shares for $16.87 per share. The transaction valued at 275,791 led to the insider holds 105,195 shares of the business.
Lonial Sagar sold 9,585 shares of TGTX for $157,098 on Jun 17 ’24. The Director now owns 99,293 shares after completing the transaction at $16.39 per share. On Mar 13 ’24, another insider, Lonial Sagar, who serves as the Director of the company, sold 5,000 shares for $15.94 each. As a result, the insider received 79,675 and left with 108,878 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 3581056000 and an Enterprise Value of 3213676032. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.54, and their Forward P/E ratio for the next fiscal year is 31.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.33 while its Price-to-Book (P/B) ratio in mrq is 20.17. Its current Enterprise Value per Revenue stands at 9.269 whereas that against EBITDA is 31.506.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $26.41, while it has fallen to a 52-week low of $6.52. The 50-Day Moving Average of the stock is -0.80%, while the 200-Day Moving Average is calculated to be 26.00%.
Shares Statistics:
Over the past 3-months, TGTX traded about 3.55M shares per day on average, while over the past 10 days, TGTX traded about 2307400 shares per day. A total of 151.42M shares are outstanding, with a floating share count of 137.98M. Insiders hold about 10.88% of the company’s shares, while institutions hold 59.36% stake in the company. Shares short for TGTX as of 1727654400 were 34398243 with a Short Ratio of 9.70, compared to 1724976000 on 29508902. Therefore, it implies a Short% of Shares Outstanding of 34398243 and a Short% of Float of 24.560000000000002.
